Your browser doesn't support javascript.
loading
Dobutamine-Induced Myoclonus in a Patient With Advanced Heart Failure and Chronic Kidney Disease.
Lee, Alexander Y; Barforoshi, Shiva; Singh, Alvin; Shrestha, Ritesh; Ha, James; Kittleson, Michelle.
Afiliação
  • Lee AY; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Barforoshi S; Department of Internal Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
  • Singh A; Department of Neurology, UCLA Ronald Reagan Medical Center, Los Angeles, California, USA.
  • Shrestha R; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Ha J; Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Kittleson M; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
JACC Case Rep ; 29(6): 102255, 2024 Mar 20.
Article em En | MEDLINE | ID: mdl-38549854
ABSTRACT
Dobutamine is a positive inotropic agent often used in treatment of cardiogenic shock. Although there are well-documented adverse effects, dobutamine-induced myoclonus is a rarely reported phenomenon. Our case offers a direct and temporally related description of myoclonus, with onset observed within hours of dobutamine initiation and complete resolution within minutes of discontinuation.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article